Deals For Genetic Data Raise Issues of Privacy, Sharing

Lock
This article is for subscribers only.

In three recent deals, drugmakers are betting that personal genetic maps will finally fulfill their early promise to unlock secrets and cure diseases.

At the same time, the agreements revived questions about privacy protections and how useful personal genetic data will prove to be.